KAYLON LEWIS: Open Payments
NPI 1073055695 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,823 in 308 payments from 30 companies in 2025. Trend: 2023 $3,810 · 2024 $7,674 · 2025 $6,823
Food & beverage: $6,753Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $616 |
| SK Life Science, Inc. | 18 | $476 |
| Axsome Therapeutics, Inc. | 14 | $414 |
| Lundbeck LLC | 22 | $393 |
| PFIZER INC. | 25 | $388 |
| Mallinckrodt Hospital Products Inc. | 14 | $378 |
| Alexion Pharmaceuticals, Inc. | 13 | $331 |
| Genentech USA, Inc. | 14 | $302 |
| Biogen, Inc. | 15 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $251 |
Products named: ACTHAR, NURTEC ODT, ULTOMIRIS, Leqembi, VYEPTI, Ocrevus Zunovo, Symbravo, QULIPTA.
Industry payments across MS — which companies pay providers there.
